TLR5 and myalgic encephalomeyelitis/chronic fatigue syndrome: Do these responses instigate primary pathogenic cascades in CD or ME/CFS—such as impeding TLR5 activation, thereby disrupting innate immune pathways—or do they merely manifest as collateral phenomena resulting from compromised intestinal barrier integrity or mucosal injury?